Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Ultimovacs on track to develop universal cancer vaccine

Cancer’s heavy burden on society has created a strong demand for new innovative therapeutic solutions. Over the last decade, immunotherapy has emerged as one of the most promising fields within oncology, and several biotech and pharma companies are exploiting this promise by developing immunotherapy-based drugs. Norwegian Ultimovacs is one of them. Their immunotherapy technology may work as a vaccine for treating all forms of cancer. BioStock takes an in-depth look at the company.Read the full article at biostock.se: https://www.biostock.se/en/ultimovacs-on-track-to-develop-universal-

Exercise of options

Issue of equityCompany announcement, 24 September 2020 at 9.15 (EEST) TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received notifications from option holders to exercise D options over 15,000 ordinary shares in the Company at an exercise price of EUR 1.09 (approx. GBP 1.00) per share under the Company’s 2015 Option Plan (“New Ordinary Shares”). The terms and conditions of the 2015 Option Plan are available on the Company’s website at https://www.faron.com/sites/default/files/Option%20Plan%

Half-year report

· Development of novel cancer immunotherapy Clevegen[®] (bexmarilimab) continues in Phase I/II MATINS trial across 10 tumour types · IV interferon beta-1a, Traumakine[®], being investigated as potential COVID-19 treatment in two ongoing global trials with preparations for US trial underway · Successful €14 million placing in April strengthens Company’s balance sheet · Additional grants of €3.3 million and €4.6 million loans awarded to drive R&D and CMC programmesHalf-year report, 24 September 2020 at 9.00 AM (EEST) TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First

Atlas Copco AB’s Nomination Committee for the Annual General Meeting 2021

Stockholm, Sweden, September 24, 2020: The following representatives of Atlas Copco AB’s shareholders, together with the Chair of the Board, Hans Stråberg, will form the nomination committee for the Annual General Meeting 2021.Representanter:Petra Hedengran, Investor AB (ordförande)Jan Andersson, Swedbank Robur fonderMikael Wiberg, AlectaJaviera Ragnartz, SEB Investment Management AB The Annual General Meeting of Atlas Copco AB will be held on April 27, 2021, at 16.00.Shareholders who wish to submit proposals to the nomination committee can do so by e-mailing the secretary of

Storytel to launch in Belgium in the fourth quarter of 2020

Storytel, one of the world’s leading audiobook and e-book streaming services, will be launching its service in Belgium during the fourth quarter of 2020. The Belgian service will be operated from the office of Storytel Netherlands.Belgium is a digitally mature market with an urban population, a strong literary storytelling tradition, and with high confidence in digital products, payment solutions, and streaming services. Belgium is also geographically adjacent to the Netherlands, one of Storytel’s strongest non-Nordic markets. Belgium is a densely populated country with 11.5 million

SRV Group Plc’s financial information in 2021

SRV GROUP PLC     STOCK EXCHANGE RELEASE     24 SEPTEMBER 2020     9.30 EET SRV Group Plc’s financial information in 2021 SRV Group Plc will publish the following financial information in 2021: · Financial Statement Release 2020 will be published on Thursday, 4 February 2021 at 8.30 am. · Annual Report 2020 (including the Financial Statements and the Report of the Board of Directors) will be published on Friday, 5 March 2021. · Interim Report for January-March 2021 will be published on Thursday, 29 April 2021 at 8.30 am. · Half-year Report for January-June 2021 will be

Revolutionary Volvo Penta-powered electric fire trucks are on their way to customers

Three pioneering fire trucks featuring Volvo Penta electric drivelines are on their way to fire departments in Berlin, Amsterdam and Dubai to begin real-world customer testing.Volvo Penta  has developed an electric driveline for leading fire service vehicle manufacturer Rosenbauer’s  pioneering fire truck, named “Revolutionary Technology” (RT). The truck – which features groundbreaking drive technology, vehicle architecture, operability and connectivity – was

HKScan Corporation’s financial reporting in 2021

HKScan Corporation, Stock Exchange Release, 24 September 2020, at 9:00 Finnish timeHKScan Corporation’s financial reporting in 2021  HKScan Corporation will publish its Financial Statement release on Thursday 4 February 2021, at approximately 8:30 a.m. EET.  The Annual Report for 2020 will be published online in March in week 11/2021 at the latest. The Annual Report will also include the Corporate Responsibility Report.  The Annual General Meeting is planned to be held in Turku on Thursday, 8 April 2021. The invitation to HKScan’s Annual General Meeting will be published later as a

ExpreS2ion and Attana have signed a Development and Supply Agreement

Hørsholm, Denmark, September 24, 2020 – ExpreS2ion Biotech Holding AB hereby announces that its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") and the biotech tools company Attana AB (“Attana”) have today signed a heads of terms agreement regarding the development and supply of novel ExpreS2ion proteins to Attana. The first target protein will be the ExpreS2ion-produced SARS-CoV-2 spike and receptor-binding-domain (RBD) antigen used in ExpreS2ion’s COVID-19 vaccine program. Attana will now be able to offer customers utilising its AVA diagnostic platform this and other novel

Mycronic appoints Nomination Committee

The Nomination Committee for Mycronic’s 2021 Annual General Meeting has been appointed in accordance with the instructions for the Nomination Committee as decided by the 2020 Annual General Meeting. The Nomination Committee comprises: · Henrik Blomquist, Bure Equity · Per Trygg, SEB Funds · Thomas Ehlin, The Fourth Swedish National Pension Fund · Patrik Tigerschiöld, Chairman The Nomination Committee represents 47.6 percent of votes and shares as of 31 August, 2020. Shareholders who wish to submit proposals to the Nomination Committee are welcome to contact the

SAS flying to China again

From 29 September, it will once again be possible to fly direct from Scandinavia to China with SAS. There have been no direct flights since 31 January, but SAS has now obtained approval from the Chinese authorities and is reopening the route from Copenhagen to Shanghai with a weekly frequency.The reopening of the route is vital for trade. With the reopening of the route, SAS is aiming to meet demand for business travel and air freight services between Scandinavia and China. At the end of October, SAS is also planning to resume flights to Beijing provided that SAS obtains the necessary

Stora Enso starts the production of new-generation formed fiber products free from plastic and PFAS

STORA ENSO OYJ PRESS RELEASE 24 September 2020 at 9:00 EESTStora Enso has started the production of formed fiber food service products at Hylte Mill in Sweden. The production ramp-up follows the investment announced in 2019 and enables the manufacture of products that are renewable, recyclable and biodegradable. The PureFiber[TM] by Stora Enso eco-product range is produced without plastic and per- and polyfluoroalkyl substances (PFAS), enabling a safe and sustainable alternative for fresh food packaging. The Group is also investing in more formed fiber capacity in Sweden and China.

Gasum enters into long-term wind power purchase agreement with ABO Wind Oy

Gasum Oy and ABO Wind Oy have entered into a long-term agreement on wind farm output. Under the ten-year Power Purchase Agreement (PPA), Gasum will begin to sell renewable wind power produced in North Ostrobothnia to its customers starting in 2023. The agreement will enable the partners Gasum and ABO Wind to increase the availability of renewable Finnish energy and at the same time more wind power will be built in Finland. Domestic wind power will increase Finland’s self-sufficiency in electricity generation.Energy company Gasum will buy electricity generated from wind energy starting in

Intrinsic Value Investors (IVI) LLP's indirect holdings in Tikkurila decreased to 4.99 percent

Tikkurila Oyj, Major Shareholders Announcement, 24 September 2020 at 8.30 p.m. (EET) Intrinsic Value Investors (IVI) LLP's indirect holdings in Tikkurila decreased to 4.99 percent Tikkurila Oyj (business ID 0197067-4) has on September 23, 2020, received a notification pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10, from Intrinsic Value Investors (IVI) LLP. The holding of the funds and accounts managed by Intrinsic Value Investors (IVI) LLP in shares of Tikkurila Oyj has decreased below the 5% threshold due to trades executed on September 22, 2020.

Kojamo Plc: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Kojamo Plc Stock Exchange Release, 24 September 2020 at 8:30 a.m. EESTFlagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act Kojamo plc (the "Company") has on 23 September 2020 received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from PGGM Vermogensbeheer B.V. According to the notification, the holding of PGGM Vermogensbeheer B.V in the Company's shares and votes has fallen below 5 per cent on 21 September 2020. This company holds a total of 11,608,439 shares corresponding to an ownership of 4.697 percent in

Public cash tender offer for all shares in Ahlstrom-Munksjö – Invitation to live webcast briefing on September 24, 2020 at 09:30 EEST

AHLSTROM-MUNKSJÖ OYJ, PRESS RELEASE SEPTEMBER 24, 2020 at 08:05 EEST Spa Holdings 3 Oy has today announced a recommended public cash tender offer for all shares in Ahlstrom-Munksjö Oyj. Ahlstrom-Munksjö and representatives of the consortium will arrange a live webcast and conference call in English today on September 24 at 09:30 (EEST). Following representatives will take part in the call; Lasse Heinonen, CEO of Ahlström Capital; Kari Kauniskangas, Chairman of the Board of Ahlström Capital; Ivano Sessa, Managing Director of Bain Capital; Jaakko Eskola, Chairman of the Board of

Ny ticker fra og med / New ticker from 25.09.2020

BRAbank ASA vil med virkning fra i morgen 25. september 2020 handle under tickeren BRABK-ME. Endringen i selskapsticker skjer som følge av tekniske forhold knyttet til den tidligere offentliggjorte fusjonen med Easybank ASA. ISIN og Instrument ID er uforandret. *Eventuelle overnattende ordre vil bli slettet av børsen etter 16:45 BRAbank ASA will effective from tomorrow 25 September 2020 trade under the ticker BRABK-ME. The change in company ticker is due to technical reasons related to the previously announced merger with Easybank ASA. ISIN number and instrument ID remains unchanged.

Veidekke ASA: To build rental apartments for Aberdeen in Gothenburg

Veidekke has been commissioned to build 160 rental apartments in Sisjödal, Gothenburg for Aberdeen Standard Investments. The project is a design and build contract that encompasses four buildings. The contract amount is NOK 208 million, and move-in for the first completed units is planned for August 2022.The Sisjön project was developed and projected by Veidekke Entreprenad in collaboration with Nordr Eiendom, formerly Veidekke Eiendom, from whom Aberdeen bought the project. With the building permit and notice to proceed in place for the 160 apartments, production has recently started. “

Spa Holdings 3 Oy announces a voluntary recommended public cash tender offer for all the shares in Ahlstrom-Munksjö Oyj

AHLSTROM-MUNKSJÖ OYJ INSIDE INFORMATION September 24, 2020 at 8:00 a.m. EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. Spa Holdings 3 Oy announces a voluntary recommended public cash tender offer for all the shares in Ahlstrom-Munksjö Oyj. · The transaction will enable the Company to reach its full potential in a changing and competitive environment · Provide

Saab Receives Order for Deployable Health to Australia

Saab has signed a contract with the Australian Department of Defence to deliver deployable health modules for the Australian Government’s Deployable Health Capability Program, Joint Project 2060. The order value is 337 MAUD (2,150 MSEK) for the years 2020-2027, including 5 years of support.Saab has partnered with Aspen Medical, Philips Healthcare Australia & NZ, Broadspectrum and Marshall Land Systems to deliver more than 550 deployable medical modules. “Saab is a strategic and long-term partner for Australian Defence and as a result of this contract, we will relocate our global

Picosun’s ALD technology boosts UVC LED performance

ESPOO, Finland, 24[th] September 2020 – Picosun Group, the leading supplier of AGILE ALD[®] (Atomic Layer Deposition) thin film coating technology, reports excellent results in UVC (ultraviolet-C) LED performance, achieved with the company’s ALD solutions. Excellent reliability and lifetime improvements of UVC LEDs have been obtained at Picosun’s customer and collaboration partner site, National Chiao Tung University (NCTU), Taiwan, using passivation and barrier films deposited with PICOSUN[®] ALD equipment(*). ALD passivation layer could potentially replace the expensive hermetic seal

EG7 successfully completes a directed issue of 8,747,131 new shares raising proceeds of approximately SEK 429 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. PLEASE READ "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE. PRESS RELEASE Stockholm, 24 September 2020 INSIDE INFORMATION: The Board of Directors of Enad Global 7 AB (publ) (“EG7” or the “Company”) has, in accordance with what was communicated

Nordic Nanovector ASA - Key information regarding potential repair offering

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN Oslo, Norway, 23 September 2020 Reference is made to the announcement by Nordic Nanovector ASA (OSE: NANO) ("Nordic Nanovector" or the "Company") on 23 September 2020 concerning a private placement with gross proceeds in the amount of NOK 231,501,725 and that the Company is

Nordic Nanovector - Private placement successfully completed

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN Oslo, Norway, 23 September 2020 Reference is made to the stock exchange release from Nordic Nanovector ASA (OSE: NANO) ("Nordic Nanovector" or the "Company"), a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through

There are no items matching the current filter
There are no more items matching the current filter
Back to top